Related references
Note: Only part of the references are listed.Cost-Effectiveness of the Manchester Approach to Identifying Lynch Syndrome in Women with Endometrial Cancer
Tristan M. Snowsill et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Feasibility of Gynaecologist Led Lynch Syndrome Testing in Women with Endometrial Cancer
Neil A. J. Ryan et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
Emma J. Crosbie et al.
GENETICS IN MEDICINE (2019)
The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis
N. A. J. Ryan et al.
GENETICS IN MEDICINE (2019)
Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting
Tristan M. Snowsill et al.
PLOS ONE (2019)
Sporadic endometrial adenocarcinoma with MMR deficiency due to biallelic MSH2 somatic mutations
Bruno Buecher et al.
FAMILIAL CANCER (2018)
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Pal Moller et al.
GUT (2017)
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
Aung Ko Win et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival
Casey M. Cosgrove et al.
GYNECOLOGIC ONCOLOGY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
Paul J. Goodfellow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Prevention for those who can pay: insurance reimbursement of genetic-based preventive interventions in the liminal state between health and disease
Anya E. R. Prince
JOURNAL OF LAW AND THE BIOSCIENCES (2015)
Lynch Syndrome Screening Should Be Considered for All Patients With Newly Diagnosed Endometrial Cancer
Anne M. Mills et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Association of Tumor Morphology With Mismatch-repair Protein Status in Older Endometrial Cancer Patients Implications for Universal Versus Selective Screening Strategies for Lynch Syndrome
Joseph T. Rabban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for lynch syndrome
Brittany A. L. Batte et al.
GYNECOLOGIC ONCOLOGY (2014)
Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables
Amy S. Joehlin-Price et al.
GYNECOLOGIC ONCOLOGY (2014)
Tumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 Years Optimizes Triage for Population-Level Germline Mismatch Repair Gene Mutation Testing
Daniel D. Buchanan et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC)
K. Newton et al.
JOURNAL OF MEDICAL GENETICS (2014)
Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome
Marilyn Huang et al.
CANCER (2013)
Risks of Colorectal and Other Cancers After Endometrial Cancer for Women With Lynch Syndrome
Aung Ko Win et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Sample Size Estimation in Prevalence Studies
Ravindra Arya et al.
INDIAN JOURNAL OF PEDIATRICS (2012)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn et al.
LANCET (2011)
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome
KM Schmeler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer).
H Hampel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gynecologic cancer as a sentinel cancer for women with hereditary nonpolyposis colorectal cancer syndrome
KH Lu et al.
OBSTETRICS AND GYNECOLOGY (2005)
Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer
DES Boks et al.
INTERNATIONAL JOURNAL OF CANCER (2002)